About CCRP2

The Rutgers University Center for COVID-19 Response and Pandemic Preparedness (CCRP2) serves as an institutional hub for COVID-19 research. Part of the Institute for Infectious and Inflammatory Diseases, CCRP2 was created to provide quick response and transformative solutions at the local, national, and international levels.

Our Mission

Led by David Alland, CCRP2 advances scientific breakthroughs in clinical, biomedical, and social science research from world-class institutes and the multidisciplinary Rutgers University community. We seek to accelerate discovery of novel diagnostics, therapeutics, and vaccines for COVID-19 and to contribute to national and international recovery through ongoing research on the societal impacts of COVID-19.

Accomplishing Our Goals

To accomplish these goals, we:

• Sponsor biomedical and social science COVID-19 research programs at Rutgers.
• Partner with public and private organizations to conduct clinical research studies testing the safety and efficacy of COVID-19 vaccines, therapeutics, and diagnostics.
• Partner with state and local officials to study and advise on COVID-19 public health policies in New Jersey.
• Develop, maintain, and share institutional resources for biomedical COVID-19 research, including Biosafety Level-3 research facilities for working with live SARS-CoV-2 virus.
• Foster collaborations between clinical, biomedical, and social science researchers with seminars and events focused on COVID-19 research across disciplines.

• Subscribe to the CCRP2 mailing list
• Contact CCRP2 to collaborate

COVID-19 Research Alliance

The COVID-19 Research Alliance serves CCRP2 as a research subcommittee, whose mission is to support the diverse faculty and researchers across Rutgers' different schools, departments, research institutes, and centers in advancing COVID-19 research.

Our mandate is to:

• Foster the exchange of information, ideas, and resources to promote productive collaborations among Rutgers researchers.
• Facilitate access to resources for COVID-19 research, including specialized Biosafety Level-3 facilities and humanized mice for in vivo infection experiments.
• Coordinate intramural research efforts and competitive extramural research applications.

• Contact Amariliz Rivera, Center for Immunity and Inflammation
• Contact Jason Yang, Center for Emerging and Re-Emerging Pathogens

COVID-19 Investigators

• All Investigators
• Biomedical Research
• Clinical Research
• Public Health Research
• Social Science Research
• Translational Research

CCRP2 Leadership

David Alland

Director, Rutgers Center for COVID-19 Response and Pandemic Preparedness

Johanna Schoen

Associate Director for Social Sciences

Jason Yang

Co-Chair, COVID-19 Research Alliance

Shobha Swaminathan

Clinical Research Site Leader

Henry Raymond

Associate Director for Public Health

Amariliz Rivera

Co-Chair, COVID-19 Research Alliance

Padmini Salgame

Chair, COVID-19 BSL-3 Advisory Committee

William Gause

Director, RBHS Institute for Infectious and Inflammatory Diseases